Klee Justin B. sold AMLX
January 16, 2026 · Form 4 insider transaction
Klee Justin B. sold 1,995 shares of Amylyx Pharmaceuticals, Inc. at $13.89 per share, a transaction worth $27.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,995
Price
$13.89
Total value
$27.7K
InsiderKlee Justin B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 16, 2026
Filing dateJanuary 20, 2026
Shares owned after3,379,398
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025.; The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.83 to $13.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.